Ameriprise
AFMD

Ameriprise’s Affimed AFMD Stock Holding History

Ameriprise’s Portfolio AFMD Stock Details AFMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8,231
Closed -$700K – 3849
2021
Q2 		$700K Buy
8,231
+5,492
+201% +$501K ﹤0.01% 3342
2021
Q1 		$217K Buy
2,739
+194
+8% +$12.6K ﹤0.01% 3686
2020
Q4 		$148K Sell
2,545
-3,827
-60% -$180K ﹤0.01% 3657
2020
Q3 		$216K Buy
6,372
+160
+3% +$6.06K ﹤0.01% 3520
2020
Q2 		$287K Buy
6,212
+3,892
+168% +$108K ﹤0.01% 3377
2020
Q1 		$37K Buy
2,320
+70
+3% +$1.67K ﹤0.01% 3592
2019
Q4 		$62K Sell
2,250
-5,560
-71% -$149K ﹤0.01% 3663
2019
Q3 		$230K Buy
7,810
+80
+1% +$2.38K ﹤0.01% 3515
2019
Q2 		$222K Buy
7,730
+2,780
+56% +$93.6K ﹤0.01% 3566
2019
Q1 		$208K Buy
4,950
+2,200
+80% +$79.1K ﹤0.01% 3540
2018
Q4 		$86K Buy
+2,750
New +$102K ﹤0.01% 3543

Other funds holding AFMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise's AFMD Position: Q3 2021 in Review

Ameriprise sold out of Affimed (AFMD) in Q3 2021, closing a stake of 8,231 shares — an estimated $700K sold.

Ameriprise first reported a position in AFMD in Q4 2018 and held it in 11 quarters. The position peaked at $700K in Q2 2021. 126 funds tracked by Wall St. Rank hold AFMD as of Q3 2021.

  • Ameriprise reported no remaining Affimed position as of Q3 2021 after selling out during the quarter.
  • Ameriprise sold 8,231 Affimed shares in Q3 2021, an estimated $700K.
  • Ameriprise first reported a position in Affimed in Q4 2018 and held it in 11 quarters.
  • Ameriprise's Affimed position peaked at $700K in Q2 2021.
  • 126 funds tracked by Wall St. Rank held Affimed as of Q3 2021.

Based on Ameriprise's 13F filing for Q3 2021, filed 15 Nov 2021.